enVVeno Medical Reports First Quarter 2023 Financial Results and Provides Corporate Update
- Ended the quarter with $34.2 million in cash and investments with quarterly burn of $4.9 million - in line with Company projections- Cash expected to support operations through the end of 2024, including release of SAVVE topline data and TAVVE …
Weiterlesen »